Cabozantinib Treatment in a Phase II Study for Patients With Hepatocellular Carcinoma (HCC) Refractory to PD-1 Inhibitors
Clinical trial NCT04767906 · COMPLETED
Trial details
- NCT number
- NCT04767906
- Sponsor
- University of Leipzig
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-14
- Primary completion
- 2024-07-19
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.